Corporate Governance

Scientific Advisors

PORxin Platform

Scientific Conferences

Scientific Publications

BPH	Prostate Cancer

PRX302

PRX321

Clinical Trials

Links

Events Calendar

Analyst Coverage

News	Media Coverage

About Vancouver

Current Opportunities

Media Kit

Investor Fact Sheet -October 2009

Graphics Library

Protox Logo, 2 color, EPS file, 700KB
Protox Logo, Grayscale, EPS file, 700KB

What's New

December 28, 2011
Protox Therapeutics Announces Closing of Additional CDN $8.3M Investment By Warburg Pincus

December 23, 2011
Protox Therapeutics Announces Additional CDN $8.3M Investment by Warburg Pincus

December 22, 2011
Protox Completes Dosing of Second Cohort of Patients in Transrectal Study

Events

November 17, 2010
- 11:15 am ET
Protox Presents at Dundee Emerging Growth Conference

Stock Quote

	LAST TRADE:	$0.35
	TRADE TIME:	3:49PM EST
	CHANGE:	$0.02 (6.06%)
	PREV CLOSE:	$0.33
	OPEN:	$0.335
	BID:	$0.34
	ASK:	$0.35